Aries Wealth Management Corbus Pharmaceuticals Holdings, Inc. Transaction History

Aries Wealth Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$0.21 - $0.53 $3,234 - $8,162	15,400 New	15,400 $4,000
Q1 2022 Apr 25, 2022	SELL	$0.32 - $0.67 $4,928 - $10,318	-15,400 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$0.6 - $1.11 $55,440 - $102,564	-92,400 Reduced 85.71%	15,400 $9,000
Q4 2021 Jan 18, 2022	BUY	$0.6 - $1.11 $50,640 - $93,684	84,400 Added 360.68%	107,800 $66,000
Q4 2020 Jan 22, 2021	SELL	$0.94 - $1.89 $9,400 - $18,900	-10,000 Reduced 29.94%	23,400 $33,000
Q3 2020 Oct 14, 2020	BUY	$1.5 - $9.38 $30,000 - $187,600	20,000 Added 149.25%	33,400 $60,000
Q2 2020 Jul 09, 2020	SELL	$4.79 - $8.39 $69,455 - $121,655	-14,500 Reduced 51.97%	13,400 $112,000
Q4 2019 Jan 13, 2020	BUY	$4.29 - $5.64 $10,725 - $14,100	2,500 Added 9.84%	27,900 $160,000
Q3 2019 Oct 22, 2019	SELL	$4.87 - $7.08 $9,740 - $14,160	-2,000 Reduced 7.3%	25,400 $118,000
Q1 2019 Apr 09, 2019	BUY	$5.76 - $8.95 $2,304 - $3,579	400 Added 1.48%	27,400 $190,000
Q2 2018 Aug 07, 2018	BUY	$5.05 - $6.8 $25,250 - $34,000	5,000 Added 22.73%	27,000 $136,000
Q1 2018 Apr 17, 2018	BUY	$5.6 - $9.25 $19,600 - $32,375	3,500 Added 18.92%	22,000 $140,000
Q4 2017 Feb 05, 2018	BUY	$6.6 - $7.78 $122,100 - $143,930	18,500	18,500 $153,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Aries Wealth Management with notifications on news.